ArticleEBioMedicine2024

Prognostic clinical and biological markers for amyotrophic lateral sclerosis disease progression: validation and implications for clinical trial design and analysis.

Michael Benatar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.